All results - Drugs and Technologies - electronic Medicines Compendium - eMC - Royal College of Psychiatrists - RCPsych - Medicines Current Awareness | Evidence search

Revised SPC: Brinavess (vernakalant) 20 mg/ml concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 31 October 2019 - Publisher: electronic Medicines compendium

SPC revised to state that for patients > 113 kg, a fixed dose of vernakalant is recommended. Initial dose is 339 mg; if conversion to sinus rhythm does not occur within 15 minutes after the end of...

Read Summary

- Remove: Medicines Current Awareness filter

- More: Guidance

Revised SPCs: Tecfidera (dimethyl fumarate) 120 and 240mg gastro-resistant hard capsules

Remove: electronic Medicines Compendium - eMC source - 24 January 2020 - Publisher: electronic Medicines compendium

SPCs updated to warn that cases of Fanconi syndrome have been reported for dimethyl fumarate products in combination with other fumaric acid esters. Early diagnosis & discontinuation are important to...

SPS comment

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Diafer (iron (III) isomaltoside 1000) 50mg/ml solution for injection

Remove: electronic Medicines Compendium - eMC source - 28 January 2020 - Publisher: electronic Medicines compendium

Sections 4.4+4.8 advise there have been reports of hypersensitivity reactions progressing to Kounis syndrome (acute allergic coronary arteriospasm that can result in MI). Section 4.6 recommends...

SPS comment

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Zydol (tramadol) all preparations

Remove: electronic Medicines Compendium - eMC source - 28 January 2020 - Publisher: electronic Medicines compendium

Section 4.4 advises “Opioids can cause sleep-related breathing disorders including central sleep apnoea (CSA) and sleep-related hypoxaemia (risk of CSA increased in dose-dependent fashion). In...

SPS comment

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Repatha SureClick (evolocumab)

Remove: electronic Medicines Compendium - eMC source - 28 February 2020 - Publisher: electronic Medicines compendium

Sections 4.2 and 4.4 have been updated to remove reference to the need for caution when used in patients with renal impairment. Section 5.1 has now been updated to include available data for use in...

More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Zinforo (ceftaroline fosamil) 600mg powder for concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 28 February 2020 - Publisher: electronic Medicines compendium

Sections 4.4 and 4.8 now advise SCARs (Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalised exanthematous pustulosis) have...

More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

New product: Melatonin Pharma Nord 3mg film-coated tablets

Remove: electronic Medicines Compendium - eMC source - 22 January 2020 - Publisher: electronic Medicines compendium

This is licensed for the short-term treatment of jet-lag in adults. The standard dose is 3 mg daily for a maximum of 5 days. The dose may be increased to 6 mg if the standard dose does not adequately...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Sivextro (tedizolid phosphate) 200 mg powder for concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 22 January 2020 - Publisher: electronic Medicines compendium

SPC has been updated to provide clarification that when reconstituted/diluted, the solution should be stored between 2°C - 8°C when in a refrigerator.

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

New product: Sunosi (solriamfetol) 75 and 150 mg film-coated tablets

Remove: electronic Medicines Compendium - eMC source - 22 January 2020 - Publisher: electronic Medicines compendium

Solriamfetol is licensed to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with narcolepsy (with/without cataplexy) or with obstructive sleep apnoea (OSA), whose...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Revised SPC: Bavencio (avelumab) 20 mg/mL concentrate for solution for infusion

Remove: electronic Medicines Compendium - eMC source - 01 November 2019 - Publisher: electronic Medicines compendium

SPC has been updated with additional information regarding the new licensed indication - in combination with axitinib, avelumab is licensed for the first-line treatment of adult patients with...

Read Summary

- More: Prescribing and Technical Information

- Remove: Medicines Current Awareness filter

Filter results by

Results for all evidence | Drugs and Technologies | electronic Medicines Compendium - eMC | Medicines Current Awareness 1 - 10 of 241 sorted by relevance / date

Revised SPC: Brinavess (vernakalant) 20 mg/ml concentrate for solution for infusion

Revised SPCs: Tecfidera (dimethyl fumarate) 120 and 240mg gastro-resistant hard capsules

Revised SPC: Diafer (iron (III) isomaltoside 1000) 50mg/ml solution for injection

Revised SPC: Zydol (tramadol) all preparations

Revised SPC: Repatha SureClick (evolocumab)

Revised SPC: Zinforo (ceftaroline fosamil) 600mg powder for concentrate for solution for infusion

New product: Melatonin Pharma Nord 3mg film-coated tablets

Revised SPC: Sivextro (tedizolid phosphate) 200 mg powder for concentrate for solution for infusion

New product: Sunosi (solriamfetol) 75 and 150 mg film-coated tablets

Revised SPC: Bavencio (avelumab) 20 mg/mL concentrate for solution for infusion